| 摘要 |
The invention is directed to lesion site marking devices and methods. Specifically, the device of this invention typically is made up of a filler body comprising a bioremodelable material comprising an extracellular matrix (ECM) material, such as small intestine submucosa (SIS) and a detectable marker associated with the filler body and adapted to mark a center of the filler body. The device of this invention may also be made up of a filler body comprising a biocompatible polymer, such as THORALON, and a detectable marker associated with the filler body and adapted to mark a center of the filler body.
|
